145 related articles for article (PubMed ID: 18528741)
1. Polymorphisms and methylation of the reduced folate carrier in osteosarcoma.
Yang R; Qin J; Hoang BH; Healey JH; Gorlick R
Clin Orthop Relat Res; 2008 Sep; 466(9):2046-51. PubMed ID: 18528741
[TBL] [Abstract][Full Text] [Related]
2. Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier.
Yang R; Li WW; Hoang BH; Kim H; Banerjee D; Kheradpour A; Healey JH; Meyers PA; Bertino JR; Gorlick R
BMC Cancer; 2008 May; 8():124. PubMed ID: 18452618
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L
J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
[TBL] [Abstract][Full Text] [Related]
4. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.
Yang R; Sowers R; Mazza B; Healey JH; Huvos A; Grier H; Bernstein M; Beardsley GP; Krailo MD; Devidas M; Bertino JR; Meyers PA; Gorlick R
Clin Cancer Res; 2003 Feb; 9(2):837-44. PubMed ID: 12576457
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the human reduced folate carrier in childhood acute lymphoblastic leukemia cells.
Liu M; Ge Y; Payton SG; Aboukameel A; Buck S; Flatley RM; Haska C; Mohammad R; Taub JW; Matherly LH
Clin Cancer Res; 2006 Jan; 12(2):608-16. PubMed ID: 16428507
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.
Sowers R; Toguchida J; Qin J; Meyers PA; Healey JH; Huvos A; Banerjee D; Bertino JR; Gorlick R
Mol Cancer Ther; 2003 Jun; 2(6):535-41. PubMed ID: 12813132
[TBL] [Abstract][Full Text] [Related]
7. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
Yang R; Kolb EA; Qin J; Chou A; Sowers R; Hoang B; Healey JH; Huvos AG; Meyers PA; Gorlick R
Clin Cancer Res; 2007 May; 13(9):2557-67. PubMed ID: 17473184
[TBL] [Abstract][Full Text] [Related]
8. Primary acute lymphoblastic leukemia cells use a novel promoter and 5'noncoding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start.
Flatley RM; Payton SG; Taub JW; Matherly LH
Clin Cancer Res; 2004 Aug; 10(15):5111-22. PubMed ID: 15297414
[TBL] [Abstract][Full Text] [Related]
9. Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells.
Ding BC; Witt TL; Hukku B; Heng H; Zhang L; Matherly LH
Biochem Pharmacol; 2001 Mar; 61(6):665-75. PubMed ID: 11266651
[TBL] [Abstract][Full Text] [Related]
10. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
Pharmacogenet Genomics; 2014 Oct; 24(10):514-21. PubMed ID: 25098908
[TBL] [Abstract][Full Text] [Related]
11. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.
Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG
J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells.
Rothem L; Aronheim A; Assaraf YG
J Biol Chem; 2003 Mar; 278(11):8935-41. PubMed ID: 12519783
[TBL] [Abstract][Full Text] [Related]
13. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of reduced folate carrier may result in folate malabsorption across intestinal brush border membrane during experimental alcoholism.
Hamid A; Wani NA; Rana S; Vaiphei K; Mahmood A; Kaur J
FEBS J; 2007 Dec; 274(24):6317-28. PubMed ID: 18005257
[TBL] [Abstract][Full Text] [Related]
15. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
Worm J; Kirkin AF; Dzhandzhugazyan KN; Guldberg P
J Biol Chem; 2001 Oct; 276(43):39990-40000. PubMed ID: 11509559
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
18. Reduced folate carrier gene silencing in multiple antifolate-resistant tumor cell lines is due to a simultaneous loss of function of multiple transcription factors but not promoter methylation.
Rothem L; Stark M; Kaufman Y; Mayo L; Assaraf YG
J Biol Chem; 2004 Jan; 279(1):374-84. PubMed ID: 14551190
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the ER-alpha Promoter Is Influenced by its Ligand Estrogen in Osteosarcoma Cells SAOS-2 In Vitro.
Tübel J; Kuntz L; Marthen C; Schmitt A; Wiest I; VON Eisenhart-Rothe R; Jeschke U; Burgkart R
Anticancer Res; 2016 Jun; 36(6):3199-204. PubMed ID: 27272849
[TBL] [Abstract][Full Text] [Related]
20. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
Gorlick R; Goker E; Trippett T; Steinherz P; Elisseyeff Y; Mazumdar M; Flintoff WF; Bertino JR
Blood; 1997 Feb; 89(3):1013-8. PubMed ID: 9028333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
